Anethole trithione

Anethole trithione, anetholtrithione, or anetholtrithion (JAN) is a drug used in the treatment of dry mouth. It is listed in the U.S. National Cancer Institute's Dictionary of Cancer Terms as being studied in the treatment of cancer.[1] Anethole trithione is an organosulfur compound, specifically, a dithiole-thione derivative.

Anethole trithione
Clinical data
ATC code
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.007.754
Chemical and physical data
FormulaC10H8OS3
Molar mass240.35 g·mol−1
3D model (JSmol)
  (verify)

Brand names

  • Felviten
  • Halpen
  • Hepasulfol - Franco-Indian Pharmaceuticals
  • Heporal
  • Mucinol - Sanofi-Aventis
  • Sialor - Paladin Laboratories; Pharmascience; Solvay; Zuoz Pharma
  • Sonicur - Solvay
  • Sulfarlem - Solvay; Aguettant; Edward Keller; Sanofi-Aventis
  • Sulfarlem S - EG Labo
  • Tiopropen
  • Tiotrifar
gollark: Excepting conlangs nobody speaks.
gollark: That's most of them.
gollark: English is more poorly designed than PHP and JavaScript.
gollark: Also conditionals sometimes, yes.
gollark: Were would be for plural or something, English is weird.

See also

References

  1. Anetholtrithione entry in the public domain NCI Dictionary of Cancer Terms. Retrieved September 13, 2008.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.